Forte Biosciences (FBRX) Tax Rate (2018 - 2026)
Forte Biosciences' (FBRX) quarterly Tax Rate came in at 1.71% in Q1 2026, down 119.58% on a QoQ basis from 8.75% in Q4 2018.
Forte Biosciences (FBRX) Tax Rate (2018 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 2 years of Tax Rate data on file, last reported at 1.71% in Q1 2026.
- On a quarterly basis, Tax Rate changed N/A year-over-year to 1.71% in Q1 2026; TTM through Mar 2026 was 1.24%, a 82.0% increase from a year earlier, with the FY2025 full-year figure at 1.43%, down 16434.0% from the prior year.
- Tax Rate for Q1 2026 stood at 1.71%, down from 8.75% in the prior quarter.
- Over the last five years, Tax Rate for FBRX reached as high as 1.71% in Q1 2026 and fell as low as 1.71% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | -1.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.71% |
| Mar 31, 2026 | -1.71% |
| Mar 31, 2026 | -1.71% |
| Dec 31, 2018 | 8.75% |
| Dec 31, 2018 | 8.75% |
| Dec 31, 2018 | 8.75% |
| Sep 30, 2018 | 134.01% |
| Sep 30, 2018 | 134.01% |
| Sep 30, 2018 | 134.01% |